Clinical trial
An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in…
NCT00487591 · Provident Clinical Research, Other · Completed
Key facts
| NCT number | NCT00487591 |
|---|---|
| Title | An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia |
| Official title | An Evaluation of Simvastatin 20 mg Plus Omacor 4 g Compared to Simvastatin 20 mg Plus Placebo in Subjects With Mixed Dyslipidemia |
| Lead sponsor | Provident Clinical Research, Other |
| Collaborators | Reliant Pharmaceuticals Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Mixed Dyslipidemia |
| Intervention type | Drug |
| Interventions | Omacor (omega-3-acid ethyl esters)plus simvastatin, simvastatin plus placebo |
| Enrollment | 40 |
| Start date | Nov 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jun 18, 2007 |
| Last update posted | May 7, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: